Skip to main content
    E

    Evolent Health Inc (EVH)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $4.83
    -0.07 (-1.53%)

    Market Cap: $554.22M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Evolent Health Inc (EVH) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Evolent Health (EVH) trades at 0.2x sales and 1.5x book value. Its P/S of 0.2x is below its 5-year median of 1.5x. Its forward P/E is 14.0x.

    Current Multiples

    Its free cash flow yield is 6.7%.

    MultipleValue
    P/E (trailing)N/A
    Forward P/E14.0x
    Price to sales0.2x
    Price to book1.5x
    Price to FCF14.9x
    EV/FCF37.3x
    PEGN/A
    FCF yield6.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 88.9% below 1.8x and its P/B is 6.3% below 1.6x.

    MultipleCurrent5-year median10-year median
    P/S0.2x1.5x1.8x
    P/B1.5x2.7x1.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 4 of the 10 year ends shown that have a P/E, its P/E ranged from 17.0x in 2024 to 200.0x in 2025. 2025 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$4.00200.0x0.2x1.1x
    2024$11.2517.0x0.5x1.3x
    2023$33.0337.5x1.9x3.5x
    2022$28.0830.9x1.9x3.3x
    2021$27.67N/A2.6x3.5x
    2020$16.03N/A1.5x2.2x
    2019$9.05N/A1.1x0.8x
    2018$19.95N/A2.5x1.4x
    2017$12.30N/A1.8x0.9x
    2016$14.80N/A2.7x1.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EVH

    What is EVH's forward P/E ratio?

    Evolent Health has a forward P/E ratio of 14.0x.

    Is EVH stock overvalued?

    GNG's valuation label for EVH is Undervalued.

    What is EVH's price to sales ratio?

    Evolent Health has a price to sales ratio of 0.2x.